As a consequence, XOR products can contribute to genetic and epigenetic changes leading to mutation, tumor initiation, and promotion that are responsible for neoplastic transformation through activation of oncogenes and/or inactivation of tumor suppressors (reviewed in 66). This evidence concerns the gene XDH and neoplasm.